This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier Launches New Open Access Journal:Case Reports In Women's Health

Stocks in this article: ENL REN RUK

AMSTERDAM, May 29, 2014 /PRNewswire/ --

Elsevier's 100th open access title now available on ScienceDirect 

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, today announced the launch of a new open access journal: Case Reports in Women's Health.

Case Reports in Women's Health publishes open access case reports covering all aspects of women's health. The scope reflects the comprehensive nature of women's health and includes not only the core areas of obstetrics and gynecology, but also the key subspecialty areas.

Editor-in-Chief Stephen L. Corson said, "We believe that case reports serve a vital function in the literature by acting as 'the canary in the coal mine'. Case Reports are detailed medical reports of the symptoms, diagnosis, treatment and follow-up of an individual patient. They often contain a demographic profile of the patient and describe a unique or novel occurrence. Many emerging diseases and conditions caused by a physician or healthcare environment due to exposure to pathogens, toxins or harmful procedures first appeared as case reports. Our aim is to be the most comprehensive source of informative case reports for busy clinicians and professionals in the diverse and growing field of women's health."

Stephen L. Corson is Professor Emeritus of Obstetrics and Gynecology at Thomas Jefferson University School of Medicine, Philadelphia, USA and Editor Emeritus of Elsevier's Journal of Minimally Invasive Gynecology. He is supported by a team of eight editors who are leading experts in their specialties.

Greyling Peoples, the Publisher responsible for Elsevier's Women's Health journal portfolio, said, "Our program aims to publish the best research and clinical developments in the field of women's health, and continue to make this content universally accessible, offer new publishing options for our authors. Case Reports in Woman ' s Health is a great addition to the program."

For more information or to submit an article please go to http://www.casereportswomenshealth.com

---

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs